Adagene (ADAG) CFO Tam Man Kin details shares, RSUs and options
Rhea-AI Filing Summary
Adagene Inc. director and Chief Financial Officer Tam Man Kin filed an initial ownership report showing direct holdings in ordinary shares and equity awards. He reports 116,583 Ordinary Shares held directly, plus 37,500 Restricted Stock Units granted under the 2021 Performance Incentive Plan, scheduled to vest in three equal installments on July 23, 2026, July 23, 2027, and July 23, 2028.
He also holds several nonqualified stock options over Adagene ordinary shares with exercise prices ranging from $1.04 to $2.032 per share and expiration dates between 2030 and 2036. Footnotes indicate which grants are time-based or performance-based and which portions are already vested and exercisable.
Positive
- None.
Negative
- None.
Insider Trade Summary
10 transactions reported
Mixed
10 txns
Insider
Tam Man Kin
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Nonqualified Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
Holdings After Transaction:
Nonqualified Stock Option (Right to Buy) — 805,853 shares (Direct);
Ordinary Shares — 116,583 shares (Direct);
Restricted Stock Unit — 37,500 shares (Direct)
Footnotes (9)
- F1. 37,500 of Restricted Stock Units ("RSUs") granted under the Adagene Inc. 2021 Performance Incentive Plan. 12,500 of RSUs shall vest on each of the following dates: 7/23/2026, 7/23/2027, and 7/23/2028.
- F2. 138,519 of time-based incentive stock options granted under the Adagene Inc. Second Amended and Restated Share Incentive Plan (pre-IPO), and all such option are fully vested and exercisable.
- F3. 74,886 of performance-based incentive stock options granted under the Adagene Inc. Second Amended and Restated Share Incentive Plan (pre-IPO), and all such option are fully vested and exercisable.
- F4. 50,000 of time-based stock option granted on 5/3/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 25,000 shares subject to this option are vested and exercisable.
- F5. 40,000 of time-based stock option granted on 12/27/2023 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 20,000 shares subject to this option are vested and exercisable.
- F6. 252,448 of time-based stock option granted on 11/17/2024 under the Adagene Inc. 2021 Performance Incentive Plan. 50% of the options shall vest on 6/30/2025 and 6/30/2026, respectively, accordingly, 126,224 shares subject to this option are vested and exercisable.
- F7. 50,000 of time-based stock option granted on 12/24/2024 under the Adagene Inc. 2021 Performance Incentive Plan. The options shall become exercisable with respect to 25% of the options on each of the first four anniversaries of the grant date. Accordingly, 12,500 shares subject to this option are vested and exercisable.
- F8. 100,000 of time-based stock option granted on 6/5/2025 under the Adagene Inc. 2021 Performance Incentive Plan, and become exercisable with respect to 25% of the stock options on each of the first four anniversaries of the grant.
- F9. 100,000 of time-based stock option granted on 2/5/2026 under the Adagene Inc. 2021 Performance Incentive Plan, and become exercisable with respect to 25% of the stock options on each of the first four anniversaries of the grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Adagene (ADAG) CFO Tam Man Kin report in this Form 3?
Tam Man Kin reports his initial ownership in Adagene as a director and CFO, including 116,583 ordinary shares, 37,500 restricted stock units, and multiple nonqualified stock option grants with various exercise prices and vesting schedules.
What restricted stock units does the Adagene (ADAG) CFO hold and when do they vest?
He holds 37,500 restricted stock units granted under the 2021 Performance Incentive Plan. These RSUs are scheduled to vest in three equal tranches of 12,500 units on July 23, 2026, July 23, 2027, and July 23, 2028, subject to plan terms.
What stock options are disclosed for the Adagene (ADAG) CFO in this Form 3?
The filing lists several nonqualified stock options over Adagene ordinary shares with exercise prices between $1.04 and $2.032 and expiration dates from 2030 through 2036, including both time-based and performance-based grants, some of which are already vested and exercisable.
Are any of the Adagene (ADAG) CFO’s stock options already vested and exercisable?
Yes. Footnotes explain that certain time-based and performance-based options, including grants of 138,519 and 74,886 options, are fully vested and exercisable, while portions of later time-based grants have partially vested according to their multi-year vesting schedules.
Does this Adagene (ADAG) Form 3 show any stock purchases or sales by the CFO?
No. The Form 3 functions as an initial ownership report, listing existing holdings in shares, restricted stock units, and options. It does not disclose any open-market purchases or sales; all entries are reported as holdings rather than new transactions.